Penumbra’s stock was up about 12% after the deal was announced Thursday morning.

Boston Scientific (NYSE: BSX) announced that it received CE mark approval for its Embold detachable coil system.

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden ...

Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

As US medtech heavyweights pour billions into bladder-control therapies for ageing populations, an Australian company is ...

Boston Scientific announced it has received CE Mark approval for the company’s Embold detachable coil system, which is a ...